TTK Healthcare (NSE:TTKHLTCARE) 3-Year Revenue Growth Rate : 3.80% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is TTK Healthcare 3-Year Revenue Growth Rate?

TTK Healthcare's Revenue per Share for the three months ended in Dec. 2023 was ₹130.18.

During the past 12 months, TTK Healthcare's average Revenue per Share Growth Rate was 6.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of TTK Healthcare was 18.90% per year. The lowest was -13.10% per year. And the median was 4.25% per year.

Competitive Comparison of TTK Healthcare's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, TTK Healthcare's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TTK Healthcare's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's 3-Year Revenue Growth Rate falls into.

TTK Healthcare 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

TTK Healthcare (NSE:TTKHLTCARE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

TTK Healthcare 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of TTK Healthcare's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

TTK Healthcare (NSE:TTKHLTCARE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTK Healthcare Ltd (NSE:TTKHLTCARE) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

507747:India

Address

No. 6, Cathedral Road, Chennai, TN, IND, 600 086

Website

https://www.ttkhealthcare.com

TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.

TTK Healthcare (NSE:TTKHLTCARE) Headlines

No Headlines